Anika Therapeutics Inc.Anika Therapeutics Inc.Anika Therapeutics Inc.

Anika Therapeutics Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪385.85 M‬USD
−5.24USD
‪−82.67 M‬USD
‪166.66 M‬USD
‪14.40 M‬
Beta (1Y)
0.54

About Anika Therapeutics Inc.

CEO
Cheryl Renee Blanchard
Headquarters
Bedford
Employees (FY)
357
Founded
1992
FIGI
BBG000BBKZD8
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ANIK is 25.97 USD — it has decreased by 0.50% in the past 24 hours. Watch Anika Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Anika Therapeutics Inc. stocks are traded under the ticker ANIK.
ANIK stock has fallen by 2.15% compared to the previous week, the month change is a 1.60% rise, over the last year Anika Therapeutics Inc. has showed a 5.36% decrease.
We've gathered analysts' opinions on Anika Therapeutics Inc. future price: according to them, ANIK price has a max estimate of 37.00 USD and a min estimate of 24.00 USD. Watch ANIK chart and read a more detailed Anika Therapeutics Inc. stock forecast: see what analysts think of Anika Therapeutics Inc. and suggest that you do with its stocks.
ANIK reached its all-time high on Oct 25, 2019 with the price of 75.72 USD, and its all-time low was 0.69 USD and was reached on Dec 29, 2000. View more price dynamics on ANIK chart.
See other stocks reaching their highest and lowest prices.
ANIK stock is 2.17% volatile and has beta coefficient of 0.54. Track Anika Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Anika Therapeutics Inc. there?
Today Anika Therapeutics Inc. has the market capitalization of ‪385.85 M‬, it has decreased by 3.34% over the last week.
Yes, you can track Anika Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Anika Therapeutics Inc. is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
ANIK earnings for the last quarter are 0.09 USD per share, whereas the estimation was −0.08 USD resulting in a 212.50% surprise. The estimated earnings for the next quarter are 0.07 USD per share. See more details about Anika Therapeutics Inc. earnings.
Anika Therapeutics Inc. revenue for the last quarter amounts to ‪40.52 M‬ USD, despite the estimated figure of ‪39.14 M‬ USD. In the next quarter, revenue is expected to reach ‪40.77 M‬ USD.
ANIK net income for the last quarter is ‪−4.51 M‬ USD, while the quarter before that showed ‪−63.00 M‬ USD of net income which accounts for 92.83% change. Track more Anika Therapeutics Inc. financial stats to get the full picture.
No, ANIK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 14, 2024, the company has 357.00 employees. See our rating of the largest employees — is Anika Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Anika Therapeutics Inc. EBITDA is ‪−3.58 M‬ USD, and current EBITDA margin is 1.07%. See more stats in Anika Therapeutics Inc. financial statements.
Like other stocks, ANIK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Anika Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Anika Therapeutics Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Anika Therapeutics Inc. stock shows the neutral signal. See more of Anika Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.